MeVis Medical Solutions AG
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also of… Read more
MeVis Medical Solutions AG (M3V) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.005x
Based on the latest financial reports, MeVis Medical Solutions AG (M3V) has a cash flow conversion efficiency ratio of 0.005x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€96.63K) by net assets (€17.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MeVis Medical Solutions AG - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how MeVis Medical Solutions AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MeVis Medical Solutions AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MeVis Medical Solutions AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Genie Networks Limited
TWO:8298
|
-0.109x |
|
Energous Corporation
NASDAQ:WATT
|
-0.180x |
|
Next Science Ltd
AU:NXS
|
2.498x |
|
Grammer AG
XETRA:GMM
|
0.483x |
|
Impero AS
CO:IMPERO
|
-1.696x |
|
TURBOMECANICA S.A.
RO:TBM
|
-0.014x |
|
Minetech Resources Bhd
KLSE:7219
|
0.022x |
|
Jayant Agro Organics Limited
NSE:JAYAGROGN
|
-0.075x |
Annual Cash Flow Conversion Efficiency for MeVis Medical Solutions AG (2006–2025)
The table below shows the annual cash flow conversion efficiency of MeVis Medical Solutions AG from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €17.83 Million | €3.88 Million | 0.218x | +23.29% |
| 2024-09-30 | €17.83 Million | €3.15 Million | 0.177x | -46.25% |
| 2023-09-30 | €17.83 Million | €5.85 Million | 0.328x | +20.52% |
| 2022-09-30 | €17.83 Million | €4.86 Million | 0.272x | -46.80% |
| 2021-09-30 | €17.83 Million | €9.13 Million | 0.512x | +215.97% |
| 2020-09-30 | €17.83 Million | €2.89 Million | 0.162x | -55.84% |
| 2019-09-30 | €17.83 Million | €6.54 Million | 0.367x | +113.19% |
| 2018-09-30 | €32.06 Million | €5.52 Million | 0.172x | -23.55% |
| 2017-09-30 | €32.51 Million | €7.32 Million | 0.225x | +111.15% |
| 2016-09-30 | €32.89 Million | €3.51 Million | 0.107x | -45.32% |
| 2015-09-30 | €33.73 Million | €6.58 Million | 0.195x | +22.25% |
| 2014-09-30 | €30.27 Million | €4.83 Million | 0.160x | -43.60% |
| 2013-09-30 | €26.45 Million | €7.48 Million | 0.283x | +21.84% |
| 2012-09-30 | €22.77 Million | €5.29 Million | 0.232x | -5.73% |
| 2011-09-30 | €20.73 Million | €5.11 Million | 0.246x | +23.38% |
| 2010-09-30 | €24.79 Million | €4.95 Million | 0.200x | +112.02% |
| 2009-09-30 | €32.61 Million | €3.07 Million | 0.094x | +5.62% |
| 2008-09-30 | €32.61 Million | €2.91 Million | 0.089x | +211.17% |
| 2007-09-30 | €30.77 Million | €-2.47 Million | -0.080x | -104.63% |
| 2006-09-30 | €2.65 Million | €4.59 Million | 1.732x | -- |